Moreover, since our GEP studies indicated that MSI2 mRNA was higher in U-CLL than M-CLL and highest in the PF of U-CLL cases (Fig. S1B, C), we analyzed MSI2 protein levels in these CLL and intraclonal subtypes. This evidence concerns the gene MSI2 and B-cell chronic lymphocytic leukemia.